1998
DOI: 10.1152/ajpendo.1998.274.1.e139
|View full text |Cite
|
Sign up to set email alerts
|

Sleep-endocrine effects of mifepristone and megestrol acetate in healthy men

Abstract: Administration of steroid hormones was demonstrated to modulate the sleep electroencephalogram (EEG) and sleep-associated hormonal secretion in specific ways. The present study was conducted to compare the effects of mifepristone (Mif), a mixed glucocorticoid (GR) and progesterone receptor (PR) antagonist, and megestrol acetate (Meg), a PR agonist. Nine healthy men were pretreated with either placebo or 200 mg Mif or 320 mg Meg, or a combination of both. Changes in plasma adrenocorticotropic hormone (ACTH), co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
20
1

Year Published

2003
2003
2016
2016

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(28 citation statements)
references
References 28 publications
7
20
1
Order By: Relevance
“…Similarly, consistent with previous findings (Wiedemann et al , 1998), the GR antagonist mifepristone increased morning rises in plasma cortisol and ACTH, resulting in higher concentrations of these hormones during the time of retrieval testing. In contrast, neither spironolactone nor mifepristone affected norepinephrine levels.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Similarly, consistent with previous findings (Wiedemann et al , 1998), the GR antagonist mifepristone increased morning rises in plasma cortisol and ACTH, resulting in higher concentrations of these hormones during the time of retrieval testing. In contrast, neither spironolactone nor mifepristone affected norepinephrine levels.…”
Section: Discussionsupporting
confidence: 92%
“…GR blockade likewise did not influence affect, attention or working memory. Sleep prior to retrieval testing was also comparable between the placebo and active agent conditions in both studies except that on the mifepristone condition subjects were longer awake and showed reduced time in REM sleep, replicating previous findings (Wiedemann et al , 1992, 1998). However, the size of the change was small and sleep disturbing effects like increased time awake or decreased REM sleep are expected to diminish rather than enhance executive functions like retrieval (Durmer and Dinges, 2005; Killgore, 2010) making it highly unlikely that these changes in sleep contributed to the improved retrieval performance during GR blockade.…”
Section: Discussionsupporting
confidence: 85%
“…For instance, synthetic progestins reduced REM/paradoxical sleep (PS) [40] and our data showed that mifepristone decreased the duration of PS episodes in male rats [12]. This suggests that progesterone must be involved in REM/PS regulation and that it may play a functional role in regulating genital mechanisms in males.…”
Section: Discussionmentioning
confidence: 81%
“…Specifically, progesterone, as well as its neuroactive metabolites, can affect sleep architecture, as was illustrated by the findings that exogenous progesterone [69] or megestrol acetate, a progesterone-receptor agonist [70], reduced REM sleep in male participants. Likewise, exogenous progesterone in rats reduced REM sleep while lengthening ROL [71].…”
Section: Sleep Across the Menstrual Cycle In Healthy Womenmentioning
confidence: 99%